Atlas FDA

Exablate Model 400 Type 1.0 & Type 1.1, Exablate Transcranial MRgFUS, Exablate Neuro, Exablate TcMRgFUS, Exablate Neurav

FDA premarket approval P150038/S027 · decided 2023-07-27

Approval details

PMA number
P150038
Supplement
S027
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Exablate Model 400 Type 1.0 & Type 1.1, Exablate Transcranial MRgFUS, Exablate Neuro, Exablate TcMRgFUS, Exablate Neurav
Generic name
MR-guided focused ultrasound system
Applicant
Insightec
Date received
2023-06-27
Decision date
2023-07-27
Days to decision
30 days
Decision code
OK30
Product code
POH
Advisory committee
Neurology
Expedited review
No
Location
Tirat Carmel
Statement
Add a second engraving machine.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.